| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. | Chief Financial Officer | Stock option (right to buy) | 600,000 | 04 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | 04 Sep 2025 | 1 | $0 | 4 | Chief Financial Officer | 05 Sep 2025, 16:06 |
| CATX | Perspective Therapeutics, Inc. | 04 Sep 2025 | 0 | $0 | 3 | Chief Financial Officer | 05 Sep 2025, 16:05 |